Endoscopic ultrasound-guided antitumor agents.
The development of linear-array endoscopic ultrasonography (EUS), with its real-time guidance of needle advancement, changed EUS from a diagnostic procedure to an interventional procedure. EUS-guided fine-needle injection (EUS-FNI) is an attractive minimally invasive delivery system with potential applications in local (intratumoral) and combination therapy against esophageal and pancreatic cancers. The evidence of the feasibility of EUS-FNI of antitumor agents has been expanding with promising results.
Division of Gastroenterology and Hepatology, H.H. Chao Comprehensive Digestive Disease Center, University of California, Irvine, 101 The City Drive, Orange, CA 92868, USA.
Yousuke
Y
Nakai
Kenneth J
KJ
Chang
D055011:Ablation Techniques; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001918:Brachytherapy; D019160:Endosonography; D015316:Genetic Therapy; D006801:Humans; D007167:Immunotherapy; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy*; D018084:Ultrasonography, Interventional
D000970:Antineoplastic Agents